AU652869B2 - Novel fumaric acid salts - Google Patents

Novel fumaric acid salts Download PDF

Info

Publication number
AU652869B2
AU652869B2 AU29815/92A AU2981592A AU652869B2 AU 652869 B2 AU652869 B2 AU 652869B2 AU 29815/92 A AU29815/92 A AU 29815/92A AU 2981592 A AU2981592 A AU 2981592A AU 652869 B2 AU652869 B2 AU 652869B2
Authority
AU
Australia
Prior art keywords
fumaric acid
formula
diazabicyclo
nonane
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU29815/92A
Other languages
English (en)
Other versions
AU2981592A (en
Inventor
Walter Heitmann
Uwe Matzel
Uwe Schon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Kali Chemie Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma GmbH filed Critical Kali Chemie Pharma GmbH
Publication of AU2981592A publication Critical patent/AU2981592A/en
Application granted granted Critical
Publication of AU652869B2 publication Critical patent/AU652869B2/en
Assigned to SOLVAY PHARMACEUTICALS GMBH reassignment SOLVAY PHARMACEUTICALS GMBH Request to Amend Deed and Register Assignors: KALI-CHEMIE PHARMA GMBH
Anticipated expiration legal-status Critical
Assigned to ABBOTT PRODUCTS GMBH reassignment ABBOTT PRODUCTS GMBH Request to Amend Deed and Register Assignors: SOLVAY PHARMACEUTICALS GMBH
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU29815/92A 1991-12-03 1992-12-02 Novel fumaric acid salts Expired AU652869B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4139763 1991-12-03
DE4139763A DE4139763A1 (de) 1991-12-03 1991-12-03 Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
AU2981592A AU2981592A (en) 1993-06-10
AU652869B2 true AU652869B2 (en) 1994-09-08

Family

ID=6446125

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29815/92A Expired AU652869B2 (en) 1991-12-03 1992-12-02 Novel fumaric acid salts

Country Status (24)

Country Link
US (1) US5324732A (2)
EP (1) EP0550383B1 (2)
JP (1) JP3180848B2 (2)
KR (1) KR100252389B1 (2)
CN (1) CN1040758C (2)
AT (1) ATE124411T1 (2)
AU (1) AU652869B2 (2)
CA (1) CA2084489C (2)
CZ (1) CZ281930B6 (2)
DE (2) DE4139763A1 (2)
DK (1) DK0550383T3 (2)
DZ (1) DZ1636A1 (2)
ES (1) ES2073900T3 (2)
FI (1) FI100053B (2)
HU (3) HU213672B (2)
IL (1) IL103819A (2)
LT (1) LTIP230A (2)
MX (1) MX9206988A (2)
NO (1) NO300687B1 (2)
NZ (1) NZ245227A (2)
PH (1) PH31114A (2)
SK (1) SK332292A3 (2)
TW (1) TW274084B (2)
ZA (1) ZA928863B (2)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4421324A1 (de) * 1994-06-17 1995-12-21 Kali Chemie Pharma Gmbh Neue 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen enthaltende Arzneimittel
ES2284709T3 (es) * 2000-09-29 2007-11-16 Solvay Pharmaceuticals B.V. Formulacion farmaceutica de liberacion sostenida independiente de la fuerza ionica.
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
AU2004260624A1 (en) * 2003-07-21 2005-02-10 Solvay Pharmaceuticals Gmbh Use of 3,7-diazabicyclo`3, 3,1 !nonane compounds for the treatment and/or prophylaxis of anti-arrhythmic events in male human patients
US20050054667A1 (en) * 2003-07-21 2005-03-10 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting anti-arrhythmic events in male human patients
WO2005030207A1 (en) * 2003-09-26 2005-04-07 Solvay Pharmaceuticals Gmbh Use of 3, 7-diazabicyclo (3.3.1) nonane compounds for the treatment of brugada syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551283C3 (de) * 1975-11-14 1981-02-19 Hokuriku Pharmaceutical Co., Ltd., Katsuyama, Fukui (Japan) Monofumarsäuresalz von 3-Pyridylmethylnikotinat und Verfahren zu seiner Herstellung
DE2658558A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
US4971992A (en) * 1989-03-27 1990-11-20 Hoechst-Roussel Pharmaceuticals Inc. Carbonate derivatives of eseroline
DE4019080A1 (de) * 1990-06-15 1991-12-19 Kali Chemie Pharma Gmbh Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
JPH05247040A (ja) 1993-09-24
DE4139763A1 (de) 1993-06-09
HK1006568A1 (en) 1999-03-05
FI925482A0 (fi) 1992-12-02
KR100252389B1 (ko) 2000-05-01
US5324732A (en) 1994-06-28
PH31114A (en) 1998-02-23
FI925482L (fi) 1993-06-04
NZ245227A (en) 1994-06-27
CZ332292A3 (en) 1993-08-11
NO924647D0 (no) 1992-12-02
CA2084489C (en) 2002-10-08
ZA928863B (en) 1993-05-13
HU210215A9 (en) 1995-02-28
HU9203698D0 (en) 1993-03-29
IL103819A (en) 1996-09-12
SK279519B6 (sk) 1998-12-02
SK332292A3 (en) 1998-12-02
MX9206988A (es) 1993-06-01
LTIP230A (en) 1994-05-15
CN1040758C (zh) 1998-11-18
CA2084489A1 (en) 1993-06-04
DE59202726D1 (de) 1995-08-03
ES2073900T3 (es) 1995-08-16
CZ281930B6 (cs) 1997-04-16
ATE124411T1 (de) 1995-07-15
CN1072931A (zh) 1993-06-09
HUT63417A (en) 1993-08-30
HU213672B (en) 1997-09-29
KR930012772A (ko) 1993-07-21
IL103819A0 (en) 1993-04-04
EP0550383A1 (de) 1993-07-07
AU2981592A (en) 1993-06-10
NO924647L (no) 1993-06-04
EP0550383B1 (de) 1995-06-28
FI100053B (fi) 1997-09-15
JP3180848B2 (ja) 2001-06-25
DK0550383T3 (da) 1995-08-28
NO300687B1 (no) 1997-07-07
DZ1636A1 (fr) 2002-02-17
TW274084B (2) 1996-04-11

Similar Documents

Publication Publication Date Title
RU2489435C2 (ru) Полезные фармацевтические соли 7-[(3r,4r) -3-гидрокси-4- гидроксиметил- пирролидин -1- илметил ]- 3,5- дигидро-пирроло [ 3,2-d] пиримидин-4-она
US3705907A (en) 4-(2-hydroxy)-3-aminopropoxy)-indole derivatives
JPH03294279A (ja) インドーロカルバゾール誘導体、その製造方法及びその使用。
US5324732A (en) Crystalline fumaric acid salts of 9,9-alkylene-3,7-diazabicyclononane compounds and pharmaceutical compositions containing them
US7795458B2 (en) Salt of (2S, 3S)-3-[[(1S)-1-isobutoxymethyl-3-methylbutyl] carbamoyl] oxirane-2-carboxylic acid
SU1272988A3 (ru) Способ получени эрголинов или их физиологически приемлемых солей
SU554815A3 (ru) Способ получени производных симмтриазоло-(4,3-а)-хинолина или их солей
US3898224A (en) 1,6,7,8-Tetrahydro-4-oxo-4H-pyrido {8 1,2-A{9 pyrimidine-9-carboalkoxy compounds
EP0977757B1 (en) 9,10-diazatricyclo 4.2.1.1?2,5 ]decane and 9,10-diazatricyclo 3.3.1.1?2,6 ]decane derivatives having analgesic activity
SU1579459A3 (ru) Способ получени производных 1-метиламинохино-линкарбоновой кислоты или их солей присоединени фармацевтически приемлемых кислот
US5401875A (en) 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments
OA11955A (en) Polymorphs of crystalline (2-benzhydryl-1-azabicycloÄ2-2-2-Üoct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as NK-1 receptor antagonists.
SU963470A3 (ru) Способ получени N @ -четвертичных производных 10-бромаймалина и 10-бромизоаймалина
HU180716B (en) Process for preparing substituted amino-alkyl-guanidines
US4321271A (en) Heterocyclic and aliphatic growth promotors
US3635962A (en) 4 - bis-morpholino- and 2
HK1006568B (en) Medicament containing crystalline fumaric acid salts of 9,9-alkylen-3,7 diazabicyclononane compounds
NO133067B (2)
US3429883A (en) S-benzoyloxymethyl-thiamine esters
JP2025537478A (ja) ジメチル－２，３－ジヒドロ－１ｈ－インデン誘導体の新規塩およびその製造方法
KR940009533B1 (ko) 헥사하이드로디벤조디옥산에서 유도된 암모늄염의 제조방법
KR800000748B1 (ko) 2-옥소-1,2,3,4-테트라히드로피리도[2,3,-d]피리미딘 유도체의 제조방법
KR20210125298A (ko) 테노포비어 알라펜아미드 헤미타르트레이트의 신규한 제조방법
KR20110081382A (ko) 결정성 아데포비어 디피복실 술폰산염 무수물, 그 제조방법 및 이를 포함하는 약제학적 조성물